Cryoport, Inc., a provider of temperature-controlled supply chain solutions for the life sciences, has signed an agreement to acquire MVE Biological Solutions, a manufacturer of vacuum insulated products and cryogenic freezer systems for the life sciences, in a cash transaction valued at $320 million. The acquisition furthers Cryoport’s position in the temperature-controlled supply chain solutions market by broadening its footprint of solutions and services, and in particular to the growing ...